Evidence map›Paper›PMID 29342275›Full record

ArticleBrain : a journal of neurology2018

Hot-spot KIF5A mutations cause familial ALS.

David Brenner, Rüstem Yilmaz, Kathrin Müller, Torsten Grehl, Susanne Petri, Thomas Meyer, Julian Grosskreutz, Patrick Weydt, Wolfgang Ruf, Christoph Neuwirth and 31 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 1 pooled it
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 1 synthesis or guideline pooled it, 229 citations in OpenAlex.

  1. Systematic review and meta-analysis of bulk RNAseq studies in human Alzheimer's disease brain tissue.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Consequences of the Novel ALS-AssociatedNeurology. Genetics · 2026
    Article
  10. KIF5A and ALS: a clinical and genetic description of a case series and review of literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. ALS Mutations Shift the Isoelectric Point of the KIF5A C Terminal Inducing Protein Aggregation and TDP-43 Mislocalization.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

41 authors at 16 institutions in 5 countries.

David BrennerNeurology Department, Ulm University, Ulm, Germany.
Rüstem YilmazNeurology Department, Ulm University, Ulm, Germany.
Kathrin MüllerNeurology Department, Ulm University, Ulm, Germany.
Torsten GrehlDepartment of Neurology, Alfried Krupp Hospital, Essen, Germany.
Susanne PetriDepartment of Neurology, Hannover Medical School, Hannover, Germany.
Thomas MeyerCharité University Hospital, Humboldt-University, Berlin, Germany.
Julian GrosskreutzDepartment of Neurology, Jena University Hospital, Jena, Germany.
Patrick WeydtNeurology Department, Ulm University, Ulm, Germany.
Wolfgang RufNeurology Department, Ulm University, Ulm, Germany.
Christoph NeuwirthKantonsspital St. Gallen, ALS Outpatient Clinic, St. Gallen, Switzerland.
Markus WeberKantonsspital St. Gallen, ALS Outpatient Clinic, St. Gallen, Switzerland.
Susana PintoDepartment of Neurosciences and Mental Health, Hospital de Santa Maria-CHLN, Lisbon, Portugal.
Kristl G ClaeysInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Berthold SchrankDepartment of Neurology, DKD HELIOS Klinik Wiesbaden, Wiesbaden, Germany.
Berit JordanDepartment of Neurology Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
Antje KnehrNeurology Department, Ulm University, Ulm, Germany.
Kornelia GüntherNeurology Department, Ulm University, Ulm, Germany.
Annemarie HübersNeurology Department, Ulm University, Ulm, Germany.
Daniel ZellerDepartment of Neurology, University of Würzburg, Würzburg, Germany.
Christian KubischInstitute of Human Genetics, Ulm University, Ulm, Germany.
Sibylle JablonkaInstitute of Clinical Neurobiology, University Hospital of Würzburg, Würzburg, Germany.
Michael SendtnerInstitute of Clinical Neurobiology, University Hospital of Würzburg, Würzburg, Germany.
Thomas KlopstockDepartment of Neurology with Friedrich-Baur-Institute, University of Munich, Munich, Germany.
Mamede de CarvalhoDepartment of Neurosciences and Mental Health, Hospital de Santa Maria-CHLN, Lisbon, Portugal.
Anne SperfeldDepartment of Neurology Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany.
Guntram BorckInstitute of Human Genetics, Ulm University, Ulm, Germany.
Alexander E VolkInstitute of Human Genetics, Ulm University, Ulm, Germany.
Johannes DorstNeurology Department, Ulm University, Ulm, Germany.
Joachim WeisInstitute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
Markus OttoNeurology Department, Ulm University, Ulm, Germany.
Joachim SchusterNeurology Department, Ulm University, Ulm, Germany.
Kelly Del TrediciNeurology Department, Ulm University, Ulm, Germany.
Heiko BraakNeurology Department, Ulm University, Ulm, Germany.
Karin M DanzerNeurology Department, Ulm University, Ulm, Germany.
Axel FreischmidtNeurology Department, Ulm University, Ulm, Germany.
Thomas MeitingerSyNergy, Munich Cluster for Systems Neurology, Ludwig Maximilians Universität München, Germany.
Tim M StromSyNergy, Munich Cluster for Systems Neurology, Ludwig Maximilians Universität München, Germany.
Albert C LudolphNeurology Department, Ulm University, Ulm, Germany.
Peter M AndersenNeurology Department, Ulm University, Ulm, Germany.
Jochen H WeishauptNeurology Department, Ulm University, Ulm, Germany.
German ALS network MND-NET
Universität Ulm · DEKantonsspital St. Gallen · CHMartin Luther University Halle-Wittenberg · DEMunich Cluster for Systems Neurology · DEUniversität Hamburg · DEUniversitätsklinikum Aachen · DEUniversitätsklinikum Würzburg · DEAlfried Krupp Hospital · DEGerman Center for Neurodegenerative Diseases · DEHospital de Santa Maria · PTHumboldt-Universität zu Berlin · DEJena University Hospital · DEMedizinische Hochschule Hannover · DEUniversity of Bonn · DEUniversity of Lisbon · PTUniversity of Würzburg · DE

Funding

Characterization of KIFAP3, a Modifier of Survival in Sporadic ALSR01NS065847 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LANDERS, JOHN E · 2010 to 2014
$1.8M
NINDS NIH HHS R01 NS065847
6 · The paper itself

Abstract

Heterozygous missense mutations in the N-terminal motor or coiled-coil domains of the kinesin family member 5A (KIF5A) gene cause monogenic spastic paraplegia (HSP10) and Charcot-Marie-Tooth disease type 2 (CMT2). Moreover, heterozygous de novo frame-shift mutations in the C-terminal domain of KIF5A are associated with neonatal intractable myoclonus, a neurodevelopmental syndrome. These findings, together with the observation that many of the disease genes associated with amyotrophic lateral sclerosis disrupt cytoskeletal function and intracellular transport, led us to hypothesize that mutations in KIF5A are also a cause of amyotrophic lateral sclerosis. Using whole exome sequencing followed by rare variant analysis of 426 patients with familial amyotrophic lateral sclerosis and 6137 control subjects, we detected an enrichment of KIF5A splice-site mutations in amyotrophic lateral sclerosis (2/426 compared to 0/6137 in controls; P = 4.2 × 10-3), both located in a hot-spot in the C-terminus of the protein and predicted to affect splicing exon 27. We additionally show co-segregation with amyotrophic lateral sclerosis of two canonical splice-site mutations in two families. Investigation of lymphoblast cell lines from patients with KIF5A splice-site mutations revealed the loss of mutant RNA expression and suggested haploinsufficiency as the most probable underlying molecular mechanism. Furthermore, mRNA sequencing of a rare non-synonymous missense mutation (predicting p.Arg1007Gly) located in the C-terminus of the protein shortly upstream of the splice donor of exon 27 revealed defective KIF5A pre-mRNA splicing in respective patient-derived cell lines owing to abrogation of the donor site. Finally, the non-synonymous single nucleotide variant rs113247976 (minor allele frequency = 1.00% in controls, n = 6137), also located in the C-terminal region [p.(Pro986Leu) in exon 26], was significantly enriched in familial amyotrophic lateral sclerosis patients (minor allele frequency = 3.40%; P = 1.28 × 10-7). Our study demonstrates that mutations located specifically in a C-terminal hotspot of KIF5A can cause a classical amyotrophic lateral sclerosis phenotype, and underline the involvement of intracellular transport processes in amyotrophic lateral sclerosis pathogenesis.

Indexed as

Family HealthAdultAgedAmyotrophic Lateral SclerosisDNA Mutational AnalysisFemaleGenetic Association StudiesHumansKinesinsLymphocytesMaleMiddle AgedMutationRNA, MessengerKIF5A protein, humanKinesinsRNA, Messenger

Identifiers

PMID29342275
PMCPMC5837483
OpenAlexW2791640295

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.